Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C.

Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.

2.

Lung eQTLs to help reveal the molecular underpinnings of asthma.

Hao K, Bossé Y, Nickle DC, Paré PD, Postma DS, Laviolette M, Sandford A, Hackett TL, Daley D, Hogg JC, Elliott WM, Couture C, Lamontagne M, Brandsma CA, van den Berge M, Koppelman G, Reicin AS, Nicholson DW, Malkov V, Derry JM, Suver C, Tsou JA, Kulkarni A, Zhang C, Vessey R, Opiteck GJ, Curtis SP, Timens W, Sin DD.

PLoS Genet. 2012;8(11):e1003029. doi: 10.1371/journal.pgen.1003029. Epub 2012 Nov 29. Erratum in: PLoS Genet. 2012 Dec;8(12). doi: 10.1371/annotation/80d53ac6-4f5d-4c34-b92b-3fec00d514ac.

3.

Evaluation of early biomarkers of muscle anabolic response to testosterone.

Chen F, Lam R, Shaywitz D, Hendrickson RC, Opiteck GJ, Wishengrad D, Liaw A, Song Q, Stewart AJ, Cummings CE, Beals C, Yarasheski KE, Reicin A, Ruddy M, Hu X, Yates NA, Menetski J, Herman GA.

J Cachexia Sarcopenia Muscle. 2011 Mar;2(1):45-56. Epub 2011 Feb 26.

4.

An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics.

Wang H, Gargano C, Lukac S, Jackson A, Beals C, Smiley P, Drexel M, Ruddy M, Herman G, Johnson-Levonas AO, Medve R, Webster L, Reicin A.

Adv Ther. 2010 Dec;27(12):963-80. doi: 10.1007/s12325-010-0084-8. Epub 2010 Nov 3.

PMID:
21052881
5.

N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone.

Bhasin S, He EJ, Kawakubo M, Schroeder ET, Yarasheski K, Opiteck GJ, Reicin A, Chen F, Lam R, Tsou JA, Castaneda-Sceppa C, Binder EF, Azen SP, Sattler FR.

J Clin Endocrinol Metab. 2009 Nov;94(11):4224-33. doi: 10.1210/jc.2009-1434. Epub 2009 Oct 16.

6.

fMRI investigation of the effect of local and systemic lidocaine on noxious electrical stimulation-induced activation in spinal cord.

Zhao F, Williams M, Welsh DC, Meng X, Ritter A, Abbadie C, Cook JJ, Reicin AS, Hargreaves R, Williams DS.

Pain. 2009 Sep;145(1-2):110-9. doi: 10.1016/j.pain.2009.05.026. Epub 2009 Jun 26.

PMID:
19560271
7.

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.

Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, Ko A, Cichanowitz N, Reicin AS.

Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16.

8.

Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.

Curtis SP, Ko AT, Bolognese JA, Cavanaugh PF, Reicin AS.

Curr Med Res Opin. 2006 Dec;22(12):2365-74.

PMID:
17265571
9.

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.

Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS.

Ann Rheum Dis. 2007 Jul;66(7):945-51. Epub 2006 Dec 1.

10.

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L; MEDAL Steering Committee.

Lancet. 2006 Nov 18;368(9549):1771-81.

PMID:
17113426
11.

Dental impaction pain model as a potential tool to evaluate drugs with efficacy in neuropathic pain.

Malmstrom K, Kotey P, McGratty M, Ramakrishnan R, Gottesdiener K, Reicin A, Wagner JA.

J Clin Pharmacol. 2006 Aug;46(8):917-24.

PMID:
16855076
12.

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.

Reiff A, Lovell DJ, Adelsberg JV, Kiss MH, Goodman S, Zavaler MF, Chen PY, Bolognese JA, Cavanaugh P Jr, Reicin AS, Giannini EH.

J Rheumatol. 2006 May;33(5):985-95. Epub 2006 Apr 1.

PMID:
16583464
13.

Response to expression of concern regarding VIGOR study.

Reicin A, Shapiro D.

N Engl J Med. 2006 Mar 16;354(11):1196-9. No abstract available.

PMID:
16544387
14.

Evaluation of the effect of perioperative rofecoxib treatment on pain control and clinical outcomes in patients recovering from gynecologic abdominal surgery: a randomized, double-blind, placebo-controlled clinical study.

Sinatra RS, Boice JA, Loeys TL, Ko AT, Kashuba MM, Jahr JS, Rhondeau S, Singla N, Cavanaugh PF Jr, Reicin AS; Protocol 159 Study Group.

Reg Anesth Pain Med. 2006 Mar-Apr;31(2):134-42.

PMID:
16543099
15.

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].

Curtis SP, Bockow B, Fisher C, Olaleye J, Compton A, Ko AT, Reicin AS.

BMC Musculoskelet Disord. 2005 Dec 1;6:58.

16.

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

Tsoukas C, Eyster ME, Shingo S, Mukhopadhyay S, Giallella KM, Curtis SP, Reicin AS, Melian A.

Blood. 2006 Mar 1;107(5):1785-90. Epub 2005 Nov 15.

17.

Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study.

Rasmussen GL, Malmstrom K, Bourne MH, Jove M, Rhondeau SM, Kotey P, Ang J, Aversano M, Reicin AS; Etoricoxib Postorthopedic Study Group.

Anesth Analg. 2005 Oct;101(4):1104-11, table of contents.

PMID:
16192529
18.

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.

Ramey DR, Watson DJ, Yu C, Bolognese JA, Curtis SP, Reicin AS.

Curr Med Res Opin. 2005 May;21(5):715-22.

PMID:
15974563
19.
20.

Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.

Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, Aversano ML, Reicin AS; Protocol 071 Study Group.

Mayo Clin Proc. 2005 Apr;80(4):470-9.

PMID:
15819283

Supplemental Content

Loading ...
Support Center